These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7348215)

  • 1. Effects of nifedipine on coronary blood flow and coronary resistance during cold pressor test and isometric exercise in patients with coronary artery disease.
    de Servi S; Mussini A; Specchia G; Bramucci E; Gavazzi A; Falcone C; Ardissino D; Guagliumi G; Bobba P
    Eur Heart J; 1980 Dec; 1(Suppl B):43-7. PubMed ID: 7348215
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease.
    Gunther S; Green L; Muller JE; Mudge GH; Grossman W
    Circulation; 1981 Apr; 63(4):849-55. PubMed ID: 7471341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
    Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA
    J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of nifedipine on regional myocardial blood flow in patients with coronary artery disease.
    Malacoff RF; Lorell BH; Mudge GH; Holman BL; Idoine J; Bifolck L; Cohn PF
    Circulation; 1982 Jan; 65(1 Pt 2):I32-7. PubMed ID: 7053296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate coronary vasoconstriction in patients with coronary artery disease: a role for nifedipine?
    Gunther S; Green L; Muller JE; Mudge GH; Grossman W
    Am J Cardiol; 1979 Oct; 44(5):793-7. PubMed ID: 386763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy in ischemic heart disease. Experience with Nifedipine (Corinfar)].
    Schwela H; Oltmanns G; Assmann I; Barthels U; Fiehring H
    Z Gesamte Inn Med; 1977 Oct; 32(19):479-83. PubMed ID: 339576
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nifedipine (Adalat) on coronary haemodynamics in patients with coronary arteriosclerotic disease.
    Simonsen S; Nitter-Hauge S
    Acta Med Scand; 1978; 204(3):179-84. PubMed ID: 696417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of nifedipine on coronary haemodynamics and exercise left ventricular function.
    Stone D
    Postgrad Med J; 1983; 59 Suppl 2():35-9. PubMed ID: 6412223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Computerized analysis of the changes induced with nifedipine in the exercise ECG].
    Visioli O; Manca C; Colla B; Albertini D; Dei Cas L
    Boll Soc Ital Cardiol; 1977; 22(7):1057-63. PubMed ID: 375952
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary haemodynamic effects of nifedipine. Comparison with glyceryl trinitrate.
    Stone DL; Stephens JD; Banim SO
    Br Heart J; 1983 May; 49(5):442-6. PubMed ID: 6404288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow-limiting coronary stenosis in the awake dog.
    Bache RJ; Tockman BA
    Circ Res; 1982 May; 50(5):678-87. PubMed ID: 6804105
    [No Abstract]   [Full Text] [Related]  

  • 12. Attenuation of coronary vascular resistance by selective alpha 1-adrenergic blockade in patients with coronary artery disease.
    Kern MJ; Horowitz JD; Ganz P; Gaspar J; Colucci WS; Lorell BH; Barry WH; Mudge GH
    J Am Coll Cardiol; 1985 Apr; 5(4):840-6. PubMed ID: 2857738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of nifedipine and nitroglycerin on coronary blood flow using intracoronary Doppler catheter.
    Chen JS; Hwang CL; Wang KY; Chen YT
    J Formos Med Assoc; 1994 Jun; 93(6):457-61. PubMed ID: 7858432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of intracoronary nifedipine on coronary sinus blood flow and myocardial oxygen consumption in patients with coronary artery disease].
    Schanzenbächer P; Liebau G; Deeg P; Kochsiek K
    Z Kardiol; 1982 Jun; 71(6):393-7. PubMed ID: 7124058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic evaluation of the action of calcium antagonists].
    Vincenzi M; Allegri P; Barbieri E; Cappelletti F; Carrozza A; De Lio U; Maiolino P; Morlino T; Ometto R
    Boll Soc Ital Cardiol; 1978; (1 Suppl):79-97. PubMed ID: 757682
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effects of verapamil and nifedipine on reactive hyperemia and ventricular arrhythmias during coronary artery reperfusion.
    Ribeiro LG; DeBauche TL; Brandon TA; Maroko PR; Miller RR
    Eur Heart J; 1980 Dec; 1(Suppl B):31-5. PubMed ID: 7348214
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism if action of calcium antagonists (nifedipine) and their value in the treatment of ischemic coronary diseases].
    Accardo G; Pazzi A; Bernardoni R
    G Clin Med; 1981 Jan; 62(1):45-50. PubMed ID: 7227709
    [No Abstract]   [Full Text] [Related]  

  • 18. Beneficial enhancement of coronary blood flow by nifedipine. Comparison with nitroglycerin and beta blocking agents.
    Engel HJ; Lichtlen PR
    Am J Med; 1981 Oct; 71(4):658-66. PubMed ID: 6792917
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary vascular reactivity and calcium antagonist therapy in patients with angina.
    Perondi R; Saino A; Zanchetti A; Mancia G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S30-6. PubMed ID: 7603075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of coronary vasoconstriction in patients with coronary artery disease.
    Gunther S; Muller JE; Mudge GH; Grossman W
    Am J Cardiol; 1981 Jan; 47(1):157-62. PubMed ID: 6779618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.